Amanote Research
Register
Sign In
P2.04-30 PD-1/PD-L1 Inhibition Might Be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1254
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
K. Yin
Z. Xie
X. Yang
W. Guo
Y. Chen
W. Yan
J. Yang
Q. Zhou
W. Zhong
Y. Wu
X. Zhang
Publisher
Elsevier BV
Related search
Pulmonary Lymphoepithelioma-Like Carcinoma
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Cytomembranic PD-L1 Expression in Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Pancreas - Open Journal
Primary Lymphoepithelioma-Like Carcinoma of the Lung
Turk Onkoloji Dergisi
Oncology
Blocking the PD-1/PD-L1 Pathway in Glioma: A Potential New Treatment Strategy
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets
Advances in Bioscience and Biotechnology
Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors
Scientific Reports
Multidisciplinary
